# Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer

> **NCT02418312** · NA · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 228 (actual)

## Conditions studied

- Peptic Ulcer

## Interventions

- **DRUG:** histamine-2 receptor antagonist
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02418312
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2019-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02418312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02418312, "Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02418312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*